Generali Asset Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
VCM
VPM
Generali Asset Management's ELV Position: Q1 2026 in Review
Generali Asset Management increased its Elevance Health (ELV) stake by 1.3% in Q1 2026, buying an estimated $79.2K and bringing the position to 18,876 shares worth $5.53M. The position accounts for 0.12% of the portfolio, ranked #174.
Generali Asset Management first reported a position in ELV in Q1 2025 and has held it in 5 quarters since. The position peaked at $11M in Q1 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Generali Asset Management held 18,876 shares of Elevance Health worth $5.53M as of Q1 2026.
- Generali Asset Management bought 241 Elevance Health shares in Q1 2026, an estimated $79.2K.
- Elevance Health made up 0.12% of Generali Asset Management's portfolio in Q1 2026, its #174 holding.
- Generali Asset Management first reported a position in Elevance Health in Q1 2025 and has held it in 5 quarters since.
- Generali Asset Management's Elevance Health position peaked at $11M in Q1 2025.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.